Advertisement

Advertisement

2019 Annual Oncofertility Conference

Issues in Oncology

By Charlotte Bath / January 25, 2020 / 2019 Annual Oncofertility Conference

Emerging Fertoprotective Therapeutic Options for Female Fertility Preservation

The trend toward delayed childbearing has meant that many women who plan to have children may be childless at the time they are diagnosed with cancer. The number of these women is likely to further in...

By Charlotte Bath / January 25, 2020 / 2019 Annual Oncofertility Conference

Comparing Options for Ovarian Tissue Cryopreservation to Preserve Fertility in Pediatric Patients With Cancer

With the pediatric cancer survival rate exceeding 80%, “we can reasonably suspect that most of these children will survive more than 5 years from their diagnosis and then go on to puberty,” when they ...

Advertisement

Advertisement

Nov

21

Today In Oncology

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma

Advertisement

© 2024 HSP News Service, L.L.C.